Healthcare costs in the United States surged to $5.3 trillion in 2024. This marked a 7.2% increase from $4.9 trillion in 2023, according to new data released by the Centers for Medicare & Medicaid Services (CMS). Moreover, the CMS report reveals that this growth...
Aspen Pharmacare faced a turbulent 2025 marked by a severe earnings downgrade and shaken investor trust. In early 2025, Aspen announced that EBITDA for the financial year would be R2 billion below prior guidance. This surprise came just weeks after the company’s...
South Africa lacks a national database to track hospital-acquired infections (HAIs), leaving a critical gap in patient safety and infection control. Health experts warn that the absence of systematic surveillance allows preventable infections and deaths to go...
Discovery Health Medical Scheme (DHMS) has reversed its controversial decision regarding claims overpayments. The administrator will now cover the costs after sustained member outcry and mounting public pressure. This marks a significant shift in strategy. The...
Global pharmaceutical companies are entering 2026 facing a high-stakes European drug pricing dispute as they seek to offset recent price concessions in the United States. Following intense pressure from President Donald Trump, who secured major drug...
